Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.
about
Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinomaNotch pathway activation is essential for maintenance of stem-like cells in early tongue cancerBayesian modeling of incidence and progression of disease from cross-sectional data.Regression analysis of a disease onset distribution using diagnosis data.Transcriptome profiling of liver of non-genetic low birth weight and long term health consequences.CURRENT STATUS AND RIGHT-CENSORED DATA STRUCTURES WHEN OBSERVING A MARKER AT THE CENSORING TIME.Two-stage and Weibull models for carcinogenesis applied to the ED01 discontinued dosing dataNumber of tumor foci predicts prognosis in papillary thyroid cancer.Statistical analysis of disease onset and lifetime data from tumorigenicity experimentsConcurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinomaTNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptomeMiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single-center clinical analysisDurable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapyEstablishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinomaExtramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance.Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinomaThe expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 CasesAssociation of dementia with death after ischemic stroke: A two-year prospective study.Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMPAn experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testingAURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients.Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.Adjacent Segment Pathology: Progressive Disease Course or a Product of Iatrogenic Fusion?Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel.CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission.Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer.Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancerPredictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.Clinical experience with radio-, chemo- and hyperthermotherapy combined trimodality on locally advanced esophageal cancerThe effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.Effects of Arsenic Trioxide on Minor Progressive High-Grade Osteosarcoma of the Extremities Metastatic to the Lung: Results of 39 Patients Treated in a Single Institution.The one-sample problem from eradication studies of chronic viral infections.Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
P2860
Q28390953-21C5DFF7-E7F7-4816-A85C-881B7610994AQ28468650-D15DEE1D-8E3B-4260-9A41-8EE6E1E9E06AQ30757247-C84ECF35-5D39-40A7-959C-C4B07AEE7981Q31120890-2E2330BB-8820-4C50-86D6-B059C2537684Q31162094-F7A23754-BBAF-47D1-ACD3-1E5EE4E0FBBCQ31162907-7838DB6E-61D5-4ECE-9422-B96F9570C1EEQ33428705-4E88ECA9-09AF-45DA-8DBA-B047D05B7749Q34896462-DA9F310C-B786-46B8-89C9-57CA962DDC93Q35035311-68608A63-69E4-4238-9431-CF47F1293D96Q35184996-EC793D72-243E-45EF-8A8B-133DFE02411FQ35269181-EFE764CA-8C23-4214-A8B6-82881BFB4F92Q35602182-66E5F42E-0C44-4C7C-B35B-9EC090120864Q35663458-1BA52304-63C1-4F14-819F-EE9042FD42CCQ35753021-9420C4F6-3CB6-4273-8CFA-1480C743B463Q35921982-4664D569-CC14-42C5-9F46-1574F5978873Q36393997-13A55B5E-B011-4054-8E92-C5C4C958817AQ36962686-85DF0474-32BE-4E7F-A8E6-72E4E7F19902Q37046861-12F5AAAB-09B9-4C2D-A8A6-5F970482E936Q37068038-73F328B4-8C66-43CA-ACDC-4A4B6F6A8138Q37204473-05E50DFD-6DAC-41BE-B3AA-E75F40BB5E54Q37217432-A8D2F9CD-3C9C-48CD-A207-0269A41C9D20Q37336908-71DD57E9-3BC1-4B0B-8708-CC4E6CC59A13Q37344059-0827DAB5-4007-4DCF-9E67-447847B606E7Q37588080-58FFA7BC-941F-4241-A931-F92230550D1EQ37687605-17DE9DFA-E7E8-4C06-BBA7-6B91480EA95CQ39048631-47214BB1-BFB1-4918-8520-4892748CB2ACQ39063102-F330BEC1-D119-400F-9DC9-079E296B19EAQ39291385-12B8EDC3-03A8-4E26-B348-914F435F1451Q40567141-B8A9C499-79A9-4462-A1AD-364CEF9DBCCEQ40649641-CF6B0A97-CF70-44D1-8701-B37C6F2FA660Q40680671-90B40737-70C7-4E5B-AF18-7C09DD0F0499Q40959922-B4B6684E-88D5-473E-A7B3-F2282A4A782AQ41028465-1C01599F-2EAB-41B2-B8AC-BF1FD1AA4285Q41213400-0289C12C-D12B-4178-BDE1-0C27845CD9FAQ41790066-78ABBC0D-5A35-494A-9332-E31013691DB7Q41830553-12506F0F-1EE4-4ACE-81AA-3F38EB9FE0E7Q42364914-A0BD72F0-03EF-4226-90F4-0E6AF845A11BQ43769479-3C584EF2-8D9A-4724-BC27-3EE109C9DC3FQ46081306-17B57CE4-7B2F-4C15-862B-576CDA786BE4Q47602844-C9677465-FCB5-4978-BC7E-DBD82C367E71
P2860
Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Nonparametric estimation of li ...... from incomplete observations.
@en
Nonparametric estimation of li ...... from incomplete observations.
@nl
type
label
Nonparametric estimation of li ...... from incomplete observations.
@en
Nonparametric estimation of li ...... from incomplete observations.
@nl
prefLabel
Nonparametric estimation of li ...... from incomplete observations.
@en
Nonparametric estimation of li ...... from incomplete observations.
@nl
P356
P1433
P1476
Nonparametric estimation of li ...... from incomplete observations.
@en
P2093
P304
P356
10.2307/2529872
P407
P577
1982-12-01T00:00:00Z